...
首页> 外文期刊>Tissue engineering, Part A >Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects.
【24h】

Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects.

机译:在纤维蛋白胶水凝胶中递送至多孔支架的未培养的骨髓单核细胞增强了临界大小的大鼠颅骨缺损内的骨再生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

For bone tissue engineering, the benefits of incorporating mesenchymal stem cells (MSCs) into porous scaffolds are well established. There is, however, little consensus on the effects of or need for MSC handling ex vivo. Culture and expansion of MSCs adds length and cost, and likely increases risk associated with treatment. We evaluated the effect of using uncultured bone marrow mononuclear cells (bmMNCs) encapsulated within fibrin glue hydrogels and seeded into porous scaffolds to regenerate bone over 12 weeks in an 8-mm-diameter, critical-sized rat cranial defect. A full factorial experimental design was used to evaluate bone formation within model poly(L-lactic acid) and corraline hydroxyapatite scaffolds with or without platelet-rich plasma (PRP) and bmMNCs. Mechanical push-out testing, microcomputed tomographical analyses, and histology were performed. PRP showed no benefit for bone formation. Cell-laden poly(L-lactic acid) scaffolds without PRP required significantly greater force to displace from surrounding tissues than control (cell-free) scaffolds, but no differences were observed during push-out testing of coral scaffolds. For bone volume formation as analyzed by microcomputed tomography, significant positive overall effects were observed with bmMNC incorporation. These data suggest that bmMNCs may provide therapeutic advantages in bone tissue engineering applications without the need for culture, expansion, and purification.
机译:对于骨组织工程,将间充质干细胞(MSCs)掺入多孔支架的好处已得到充分确立。然而,关于MSC离体处理的效果或需要的共识很少。 MSC的培养和扩增增加了长度和成本,并且可能增加了与治疗相关的风险。我们评估了使用封装在纤维蛋白胶水凝胶中的未培养的骨髓单核细胞(bmMNCs)并将其植入多孔支架中以在直径8毫米,临界尺寸的大鼠颅骨缺损中再生骨骼超过12周的效果。一个完整的析因实验设计用于评估模型聚(L-乳酸)和Corraline羟基磷灰石支架中的骨骼形成,有或没有富血小板血浆(PRP)和bmMNC。进行了机械推出测试,显微计算机断层扫描分析和组织学检查。 PRP对骨骼形成没有好处。与对照(无细胞)支架相比,无PRP的载有细胞的聚(L-乳酸)支架需要从周围组织移出的力要大得多,但是在推出珊瑚支架时未观察到差异。对于通过微计算机断层摄影术分析的骨体积形成,bmMNC合并观察到显着的积极总体效果。这些数据表明,bmMNCs可以在骨组织工程应用中提供治疗优势,而无需培养,扩增和纯化。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号